Skip to main content

Advertisement

Table 2 Clinical Characteristics of the Sample

From: Correlates of weight gain during long-term risperidone treatment in children and adolescents

Characteristic
Psychiatric Diagnoses, n (%)
Attention Deficit Hyperactivity Disorder 96 (87)
Disruptive Behavior Disorder 100 (91)
Anxiety Disorder 36 (33)
Tic Disorder 24 (22)
Depressive Disorder 12 (11)
Pervasive Developmental Disorder 14 (13)
Psychotic Disorder 1 (1)
Pharmacotherapy
Risperidone Dose, mg/d 1.4 (±1.1)
Risperidone Dose, mg/kg/d 0.03 (±0.02)
Age at Start of Risperidone, yrs 9.1 (±2.8)
Treatment Duration, yrs 2.5 (±1.7)
Psychostimulants, n (%) 78 (71)
Psychostimulants Dose, mg/d a 59.2 (±28.6)
Psychostimulants Dose, mg/kg/d a 1.35 (±0.70)
Psychostimulants Treatment Duration, yrs 4.8 (±2.7)
SSRIs, n (%) 55 (50)
  Fluoxetine 21 (19)
  Sertraline 16 (15)
  Citalopram/Escitalopram 18 (16)
SSRI Dose, unit per day b 1.30 (±0.83)
SSRI Treatment Duration, yrs 2.6 (±2.1)
α2-agonists, n (%) 35 (32)
  1. a All dosages of psychostimulants were expressed in methylphenidate equivalents for amphetamines (x 2) [33].
  2. b One SSRI unit is equivalent to a daily dose of 10 mg of escitalopram, 20 mg of fluoxetine, citalopram, or paroxetine, and 50 mg of sertraline or fluvoxamine [25].